down arrow

Ganga Pharma.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE615T01017
  • NSEID:
  • BSEID: 539680
INR
11.18
1.01 (9.93%)
BSENSE

Apr 11, 11:54 AM

BSE+NSE Vol: 32.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 5.78% vs 3.91% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 1,121.10% vs -88.78% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -4.63% vs -0.60% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 18.60% vs 3.74% in Mar 2023

Compare Profit and Loss Results of Ganga Pharma.
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2.00
20,275.00
-20,273.00
-99.99%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2.00
20,275.00
-20,273.00
-99.99%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
180.00
-180.00
-100.00%
Raw Materials Consumed
1.00
5,423.00
-5,422.00
-99.98%
Power & Fuel Cost
0.00
450.00
-450.00
-100.00%
Employee Cost
0.00
2,373.00
-2,373.00
-100.00%
Operating Expenses
0.00
1,195.00
-1,195.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2,567.00
-2,567.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
396.00
-396.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2.00
14,775.00
-14,773.00
-99.99%
Operating Profit (PBDIT) excl Other Income
0.00
5,499.00
-5,499.00
-100.00%
Other Income
0.00
553.00
-553.00
-100.00%
Operating Profit (PBDIT)
0.00
6,053.00
-6,053.00
-100.00%
Interest
0.00
784.00
-784.00
-100.00%
Profit before Depriciation and Tax
0.00
5,269.00
-5,269.00
-100.00%
Depreciation
0.00
1,600.00
-1,600.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
3,668.00
-3,668.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
3,449.00
-3,449.00
-100.00%
Provision for Tax
0.00
591.00
-591.00
-100.00%
Profit After Tax
0.00
2,858.00
-2,858.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
12,790.00
-12,790.00
-100.00%
Profit Available for appropriations
0.00
15,649.00
-15,649.00
-100.00%
Appropriations
0.00
15,649.00
-15,649.00
-100.00%
Equity Dividend (%)
0%
1350%
-1,350.00
Earnings Per Share
0.11
11.9
-11.79
-99.08%
Profit And Loss - Net Sales
Net Sales 2.74 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 5.78% vs 3.91% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.06 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1,121.10% vs -88.78% in Mar 2023

Profit And Loss - Interest
Interest 0.18 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -4.63% vs -0.60% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 0.05 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 18.60% vs 3.74% in Mar 2023